In vitro activities of fluoroquinolones against antibiotic-resistant blood culture isolates of viridans group streptococci from across Canada.
about
DNA relatedness, phenotypic characteristics, and antimicrobial susceptibilities of Globicatella sanguinis strains.Antimicrobial susceptibilities and clinical sources of Facklamia speciesActivities of new fluoroquinolones, ketolides, and other antimicrobials against blood culture isolates of viridans group streptococci from across Canada, 2000.Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniaeFluoroquinolone resistance in penicillin-resistant Streptococcus pneumoniae clones, Spain.Molecular basis of resistance to macrolides and other antibiotics in commensal viridans group streptococci and Gemella spp. and transfer of resistance genes to Streptococcus pneumoniae.Antimicrobial susceptibility patterns among viridans group streptococcal isolates from infective endocarditis patients from 1971 to 1986 and 1994 to 2002Horizontal transfer of parC and gyrA in fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae.Interspecies recombination contributes minimally to fluoroquinolone resistance in Streptococcus pneumoniaeIn vitro activities of garenoxacin (BMS-284756) against Streptococcus pneumoniae, viridans group streptococci, and Enterococcus faecalis compared to those of six other quinolones.In vitro activity of telithromycin against viridans group streptococci and Streptococcus bovis isolated from blood: antimicrobial susceptibility patterns in different groups of species.Potencies of newer fluoroquinolones against Viridans group Streptococciisolated in 637 cases of bloodstream infection in the SENTRY Antimicrobial Surveillance Program (1997 to 1999): beyond Canada!Fitness of Streptococcus pneumoniae fluoroquinolone-resistant strains with topoisomerase IV recombinant genes.
P2860
Q33974031-D37FCEEB-F5F9-4164-9BC1-1B5A2F723C0EQ33980225-2BF2D6E9-FEBD-44C5-8ABD-FD69E7DCC5DAQ34107331-FED84F4F-3585-4613-8887-18FDE73E3904Q35102420-9E82AAAC-5700-4652-8FF7-B9BDEDC4C7C7Q35880792-6601FC0A-9830-44D3-99BA-285C55826F22Q37488714-A26224CA-EB77-4A65-9C1B-620A76F071C5Q37598714-CF086021-8F9E-4211-B2C5-7672E79F28E1Q39473366-4B222C10-6C96-4D8A-A3E1-59381A75F1D3Q39478343-F65D731A-3DB7-4BE8-8654-AB3EC12569C7Q40130516-E5F49E24-ACD2-4A6D-85F5-E9B09F8E4B36Q41007983-AF70A7EE-0AF3-467D-B7BF-8358C3A285A6Q42730107-99EF9876-D227-4044-A5A8-342F6FDDCF1CQ43063844-2287A70B-3224-4F61-B84B-345EB4AB09A9
P2860
In vitro activities of fluoroquinolones against antibiotic-resistant blood culture isolates of viridans group streptococci from across Canada.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
In vitro activities of fluoroq ...... reptococci from across Canada.
@ast
In vitro activities of fluoroq ...... reptococci from across Canada.
@en
type
label
In vitro activities of fluoroq ...... reptococci from across Canada.
@ast
In vitro activities of fluoroq ...... reptococci from across Canada.
@en
prefLabel
In vitro activities of fluoroq ...... reptococci from across Canada.
@ast
In vitro activities of fluoroq ...... reptococci from across Canada.
@en
P2093
P2860
P1476
In vitro activities of fluoroq ...... reptococci from across Canada.
@en
P2093
Matsumura S
Pong-Porter S
de Azavedo JC
P2860
P304
P407
P577
1999-09-01T00:00:00Z